🔎 Trials Near Me

Início › Doença Falciforme › Geórgia

Ensaios clínicos de Doença Falciforme em Geórgia

25 estudos para Doença Falciforme estão buscando participantes em locais em Geórgia.

Cidades em Geórgia

Texto oficial do estudo (Inglês)

A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE)

  • Augusta University Georgia, Augusta
  • WCG Sonar Clinical Research, Riverdale
RecrutandoFase 3
Idades de 12 a 100 · Todos os sexos · Atualizado em 28 de set. de 2026 · NCT06439082

A Phase 1b, Open-Label Study of DISC-3405 in Participants With Sickle Cell Disease (SCD)

  • Emory University, Atlanta
  • Augusta University, Augusta
RecrutandoFase 1
Idades 18 e acima · Todos os sexos · Atualizado em 23 de set. de 2026 · NCT07187973

A Research Study Looking at Long-term Treatment With Etavopivat in People With Sickle Cell Disease or Thalassaemia

  • Children's Healthcare Atlanta, Atlanta
RecrutandoFase 3
Idades 2 e acima · Todos os sexos · Atualizado em 18 de set. de 2026 · NCT06609226

A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease

  • Children's Healthcare Atlanta, Atlanta
RecrutandoFase 3
Idades 12 e acima · Todos os sexos · Atualizado em 17 de set. de 2026 · NCT06612268

Assessing Molecular Mechanisms and Effects of Music Therapy in Youth With Sickle Cell Disease Using Single-cell RNA-sequencing

  • Children's Healthcare of Atlanta, Atlanta
Recrutando
Idades de 8 a 18 · Todos os sexos · Atualizado em 10 de set. de 2026 · NCT07562451

A Study to Evaluate BMS-986470 in Healthy Volunteers and Participants With Sickle Cell Disease

  • Winship Cancer Institute of Emory University, Atlanta
RecrutandoFase 1/2Voluntários saudáveis bem-vindos
Idades 18 e acima · Todos os sexos · Atualizado em 18 de ago. de 2026 · NCT06481306

A Phase 2/3 Study of Osivelotor in Adult and Adolescent Participants With SCD

  • Children's Center for Advanced Pediatrics, Atlanta
RecrutandoFase 2/3
Idades 12 e acima · Todos os sexos · Atualizado em 18 de ago. de 2026 · NCT05431088

ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders

  • Comprehensive Bleeding Disorders Center at Emory University and Children's Healthcare of Atlanta, Atlanta
  • Emory/Children's Health Care of Atlanta, Atlanta
  • Memorial Health University Medical Center, Savannah
RecrutandoEstudo observacional
Todas as idades · Todos os sexos · Atualizado em 17 de ago. de 2026 · NCT04398628

Safety, Efficacy, and Pharmacokinetics of CSL889 in Adults and Adolescents With Sickle Cell Disease During Vaso-Occlusive Crisis

  • Arthur M. Blank Hospital-Children's Healthcare of Atlanta, Atlanta
RecrutandoFase 2
Idades 12 e acima · Todos os sexos · Atualizado em 14 de ago. de 2026 · NCT06699849

Safety of Anumigilimab (CSL324) in Adults With Sickle Cell Disease (SCD)

  • Arthur M. Blank Hospital- Children's Healthcare of Atlanta, Atlanta
RecrutandoFase 2
Idades 18 e acima · Todos os sexos · Atualizado em 5 de ago. de 2026 · NCT07224360

Arginine Therapy for the Treatment of Pain in Children With Sickle Cell Disease

  • Children's Healthcare fo Atlanta at Hughes Spalding, Atlanta
  • Children's Healthcare of Atlanta at Arthur M. Blank Hospital, Atlanta
RecrutandoFase 1/2
Idades de 7 a 21 · Todos os sexos · Atualizado em 29 de jul. de 2026 · NCT02447874

Cooperative Assessment of Late Effects for SCD Curative Therapies

  • Emory University School of Medicine, Atlanta
RecrutandoEstudo observacional
Idades de 4 a 65 · Todos os sexos · Atualizado em 27 de jul. de 2026 · NCT05153967

Rollover Study for Patients With Sickle Cell Disease Who Have Completed a Prior Novartis-Sponsored Crizanlizumab Study

  • Augusta University Georgia, Augusta
RecrutandoFase 4
6 Months – 100 Years · Todos os sexos · Atualizado em 8 de jun. de 2026 · NCT04657822

Ruxolitinib-Enhanced Haplo HCT for Children and Young Adults With Sickle Cell Disease

  • Children's Healthcare of Atlanta, Atlanta
RecrutandoFase 1/2
Idades de 12 a 45 · Todos os sexos · Atualizado em 4 de jun. de 2026 · NCT07252050

Comparing the Effectiveness of Matched Related Donor Hematopoietic Stem Cell Transplantation to Disease Modifying Therapy in Pediatric Patients With Sickle Cell Disease

  • Children's Healthcare of Atlanta (MRD-HCT), Atlanta
RecrutandoEstudo observacional
Idades de 3 a 20 · Todos os sexos · Atualizado em 4 de jun. de 2026 · NCT06941389

Clinical and Biomarker Effects of Depot Medroxyprogesterone Acetate in Females With Sickle Cell Disease

  • Emory University, Atlanta
RecrutandoFase 4
Idades de 18 a 50 · Mulheres · Atualizado em 28 de mai. de 2026 · NCT06665997

A Socio-ecological Approach for Improving Self-management in Adolescents With SCD

  • Children's Healthcare of Atlanta, Atlanta
Recrutando
Idades de 13 a 21 · Todos os sexos · Atualizado em 11 de mai. de 2026 · NCT06290401

Study of a Single Dose of a 21-valent Pneumococcal Conjugate Vaccine in Children and Adolescents With Sickle Cell Disease

  • Site # 8400006, Atlanta
  • Site # 8400002, Atlanta
RecrutandoFase 3
Idades de 2 a 17 · Todos os sexos · Atualizado em 15 de abr. de 2026 · NCT07247188

Prophylactic Transfusion In Pregnant in Women With Sickle Cell Disease

  • Grady Health System, Atlanta
RecrutandoFase 4Voluntários saudáveis bem-vindos
Idades 18 e acima · Mulheres · Atualizado em 18 de fev. de 2026 · NCT06979492

A Long-term Follow-up Study in Patients Who Received BEAM-101

  • Children's Healthcare of Atlanta - Aflac Cancer and Blood Disorders Center- Egleston, Atlanta
RecrutandoEstudo observacional
Idades de 14 a 37 · Todos os sexos · Atualizado em 28 de jan. de 2026 · NCT07373639

Trans-auricular Nerve Stimulation as an Innovative Approach to the Treatment of Pain in Pediatric Patients Suffering From Sickle Cell Disease

  • Children's Hospital of Atlanta: Eagelston, Atlanta
Recrutando
Idades de 7 a 18 · Todos os sexos · Atualizado em 26 de jan. de 2026 · NCT07090668

Study of Panobinostat (LBH589) in Patients With Sickle Cell Disease

  • Augusta University, Augusta
RecrutandoFase 1
Idades 18 e acima · Todos os sexos · Atualizado em 9 de jan. de 2026 · NCT01245179

Peer Support for Adolescents and Emerging Adults With Sickle Cell Pain

  • Children's Healthcare of Atlanta, Atlanta
Recrutando
Idades de 16 a 30 · Todos os sexos · Atualizado em 7 de jan. de 2026 · NCT06374238

Integrative Training Program for Pediatric Sickle Cell Pain

  • Children's Healthcare of Atlanta, Atlanta
  • Arthur M. Blank Hospital | Children's Healthcare of Atlanta, Atlanta
Recrutando
Idades de 12 a 18 · Todos os sexos · Atualizado em 14 de nov. de 2025 · NCT06691867

Recruitment and Engagement in Care to Impact Practice Enhancement (RECIPE) for Sickle Cell Disease

  • Augusta University, Augusta
RecrutandoEstudo observacional
Idades 18 e acima · Todos os sexos · Atualizado em 22 de jun. de 2025 · NCT06385886

Fonte: ClinicalTrials.gov, dados obtidos em 5 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.